RedHill Biopharma reported 89.8K in Interest Expense on Debt for its fiscal quarter ending in June of 2024.


Interest Expense On Debt Change Date
Clal Biotechnology 2.42M 640K Sep/2020
Compugen 1.28M 507K Sep/2024
Cronos Group USD 0 7K Sep/2024
RedHill Biopharma 89.8K 31.69M Jun/2024